The University of Chicago Header Logo

Connection

Ardaman Shergill to Vascular Endothelial Growth Factor A

Back to Details
This is a "connection" page, showing publications Ardaman Shergill has written about Vascular Endothelial Growth Factor A.
Ardaman Shergill
Connection Strength
0.047
Vascular Endothelial Growth Factor A
  1. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023 07 01; 402(10395):41-53.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.